Showing results (161-170 of 562) with videos related to
Sort By:
Pageof 57
Heart, Lung & Circulation|December 21, 2019
Women and Cardiovascular Disease: Pregnancy, the Forgotten Risk FactorClare Arnott, Sanjay Patel, Jon Hyett, et al.The Journal of Antimicrobial Chemotherapy|September 11, 2019
Outpatient parenteral antimicrobial therapy: updated recommendations from the UKAnn L N Chapman, Sanjay Patel, Carolyne Horner, et al.Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 11, 2026
Mid-Term Outcomes of Percutaneous Deep Venous Arterialization Using the LimFlow SystemAhmed M Morshed, Narayanan Thulasidasan, Harishankar Nair, et al.The Journal of Cardiovascular Surgery|May 10, 2023
Contemporary approaches for the management of aorto-iliac occlusive diseaseArsalan Wafi, Mohamed S Hosny, Sanjay Patel, et al.International Journal of Molecular Sciences|April 13, 2023
The Prognostic, Diagnostic, and Therapeutic Potential of TRAIL Signalling in Cardiovascular DiseasesElaina Kelland, Manisha S Patil, Sanjay Patel, et al.Cells|December 11, 2019
MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients-A Systematic ReviewJennifer Y Barraclough, Michelyn Joan, Mugdha V Joglekar, et al.International Journal of STD & AIDS|August 18, 2018
Congenital syphilis presenting with liver lesionsHeather Deall, Saul N Faust, Emanuela Pelosi, et al.International Journal of Clinical Pharmacology and Therapeutics|October 18, 2012
Pharmacokinetics of single and multiple oral doses of 5 mg linagliptin in healthy Chinese volunteersChristian Friedrich, Xiaojin Shi, Peter Zeng, et al.Heart, Lung & Circulation|April 20, 2015
Pulmonary Vein Isolation Compared to Rate Control in Patients with Atrial Fibrillation: A Systematic Review and Meta-analysisKaivan Vaidya, Clare Arnott, Anne Russell, et al.Cardiovascular Diabetology|January 12, 2012
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programmeOdd Erik Johansen, Dietmar Neubacher, Maximilian von Eynatten, et al.Pageof 57